# Medrol Dosepak for Outpatient Total Knee Arthroplasty

> **NCT05097976** · PHASE4 · RECRUITING · sponsor: **Rush University Medical Center** · enrollment: 420 (estimated)

## Conditions studied

- Total Knee Arthroplasty

## Interventions

- **DRUG:** Methylprednisolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05097976
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-12
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05097976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05097976, "Medrol Dosepak for Outpatient Total Knee Arthroplasty". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05097976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*